Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 521

1.

Baseline MRI inflammation is not a determinant of 5-year bone mineral density loss in patients with early spondyloarthritis.

Fechtenbaum M, Molto A, Roux C, Goupille P, Chevret S, Briot K.

Joint Bone Spine. 2019 Oct 10. pii: S1297-319X(19)30146-0. doi: 10.1016/j.jbspin.2019.09.016. [Epub ahead of print]

PMID:
31606496
2.

Impact of Counseling Methods on HIV Retesting Uptake in At-Risk Individuals: A Randomized Controlled Study.

Salvadori N, Decker L, Ngo-Giang-Huong N, Mary JY, Chevret S, Arunothong S, Adam P, Khamduang W, Samleerat T, Luangsook P, Suksa-Ardphasu V, Achalapong J, Rouzioux C, Sirirungsi W, Jourdain G.

AIDS Behav. 2019 Oct 11. doi: 10.1007/s10461-019-02695-2. [Epub ahead of print]

PMID:
31605294
3.

Direct admission to the intensive care unit from the emergency department and mortality in critically ill hematology patients.

Peyrony O, Chevret S, Meert AP, Perez P, Kouatchet A, Pène F, Mokart D, Lemiale V, Demoule A, Nyunga M, Bruneel F, Lebert C, Benoit D, Mirouse A, Azoulay E.

Ann Intensive Care. 2019 Oct 2;9(1):110. doi: 10.1186/s13613-019-0587-7.

PMID:
31578641
4.

Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis.

Rubenstein E, Maldini C, Gonzalez-Chiappe S, Chevret S, Mahr A.

Rheumatology (Oxford). 2019 Sep 14. pii: kez385. doi: 10.1093/rheumatology/kez385. [Epub ahead of print]

PMID:
31529073
5.

Center effect in intubation risk in critically ill immunocompromised patients with acute hypoxemic respiratory failure.

Dumas G, Demoule A, Mokart D, Lemiale V, Nseir S, Argaud L, Pène F, Kontar L, Bruneel F, Klouche K, Barbier F, Reignier J, Stoclin A, Louis G, Constantin JM, Wallet F, Kouatchet A, Peigne V, Perez P, Girault C, Jaber S, Cohen Y, Nyunga M, Terzi N, Bouadma L, Lebert C, Lautrette A, Bigé N, Raphalen JH, Papazian L, Benoit D, Darmon M, Chevret S, Azoulay E.

Crit Care. 2019 Sep 6;23(1):306. doi: 10.1186/s13054-019-2590-7.

6.

Association between early advanced life support and good neurological outcome in out of hospital cardiac arrest: A propensity score analysis.

Michelland L, Adnet F, Escutnaire J, Baker C, Hubert H, Chevret S.

J Eval Clin Pract. 2019 Aug 29. doi: 10.1111/jep.13268. [Epub ahead of print]

PMID:
31466139
7.

ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials.

Grafféo N, Latouche A, Le Tourneau C, Chevret S.

Comput Biol Med. 2019 Aug;111:103339. doi: 10.1016/j.compbiomed.2019.103339. Epub 2019 Jun 24.

PMID:
31442762
8.

Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter study.

Jachiet M, Nosbaum A, Staumont-Sallé D, Seneschal J, Viguier M, Soria A, Barbaud A, Carriou AC, Chuffart-Delplanque M, Darrigade AS, Fite C, de Masson A, Bagot M, Chevret S, Bouaziz JD; French Group of Research and Study in Atopic Dermatitis (GREAT) from the French Society of Dermatology (SFD).

J Eur Acad Dermatol Venereol. 2019 Jul 5. doi: 10.1111/jdv.15774. [Epub ahead of print] No abstract available.

PMID:
31273834
9.

High cutoff haemodialysis in myeloma cast nephropathy: further investigation is needed.

Bridoux F, Chevret S, Fermand JP.

Lancet Haematol. 2019 Jul;6(7):e347. doi: 10.1016/S2352-3026(19)30090-0. No abstract available.

PMID:
31244474
10.

Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy.

Hervé D, Ibos-Augé N, Calvière L, Rogan C, Labeyrie MA, Guichard JP, Godin O, Kossorotoff M, Habert MO, Lasserve ET, Chevret S, Chabriat H.

Neurology. 2019 Jul 23;93(4):e388-e397. doi: 10.1212/WNL.0000000000007819. Epub 2019 Jun 25.

11.

Mottling score is a strong predictor of 14-day mortality in septic patients whatever vasopressor doses and other tissue perfusion parameters.

Dumas G, Lavillegrand JR, Joffre J, Bigé N, de-Moura EB, Baudel JL, Chevret S, Guidet B, Maury E, Amorim F, Ait-Oufella H.

Crit Care. 2019 Jun 10;23(1):211. doi: 10.1186/s13054-019-2496-4.

12.

Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort.

Schmidt M, Pham T, Arcadipane A, Agerstrand C, Ohshimo S, Pellegrino V, Vuylsteke A, Guervilly C, McGuinness S, Pierard S, Breeding J, Stewart C, Ching SSW, Camuso JM, Stephens RS, King B, Herr D, Schultz MJ, Neuville M, Zogheib E, Mira JP, Rozé H, Pierrot M, Tobin A, Hodgson C, Chevret S, Brodie D, Combes A.

Am J Respir Crit Care Med. 2019 Oct 15;200(8):1002-1012. doi: 10.1164/rccm.201806-1094OC.

PMID:
31144997
13.

Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy.

Bauer PR, Chevret S, Yadav H, Mehta S, Pickkers P, Bukan RB, Rello J, van de Louw A, Klouche K, Meert AP, Martin-Loeches I, Marsh B, Socias Crespi L, Moreno-Gonzalez G, Buchtele N, Amrein K, Balik M, Antonelli M, Nyunga M, Barratt-Due A, Bergmans DCJJ, Spoelstra-de Man AME, Kuitunen A, Wallet F, Seguin A, Metaxa V, Lemiale V, Burghi G, Demoule A, Karvunidis T, Cotoia A, Klepstad P, Møller AM, Mokart D, Azoulay E; Efraim investigators and the Nine-I study group.

Eur Respir J. 2019 Jul 25;54(1). pii: 1802442. doi: 10.1183/13993003.02442-2018. Print 2019 Jul.

PMID:
31109985
14.

High-Flow Oxygen Therapy for Respiratory Failure in Immunocompromised Patients-Reply.

Azoulay E, Chevret S, Demoule A.

JAMA. 2019 May 14;321(18):1827. doi: 10.1001/jama.2019.2064. No abstract available.

PMID:
31087018
15.

Influenza and associated co-infections in critically ill immunosuppressed patients.

Martin-Loeches I, Lemiale V, Geoghegan P, McMahon MA, Pickkers P, Soares M, Perner A, Meyhoff TS, Bukan RB, Rello J, Bauer PR, van de Louw A, Taccone FS, Salluh J, Hemelaar P, Schellongowski P, Rusinova K, Terzi N, Mehta S, Antonelli M, Kouatchet A, Klepstad P, Valkonen M, Landburg PP, Barratt-Due A, Bruneel F, Pène F, Metaxa V, Moreau AS, Souppart V, Burghi G, Girault C, Silva UVA, Montini L, Barbier F, Nielsen LB, Gaborit B, Mokart D, Chevret S, Azoulay E; Efraim investigators and the Nine-I study group.

Crit Care. 2019 May 2;23(1):152. doi: 10.1186/s13054-019-2425-6.

16.

Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.

Ouedraogo E, Gottlieb J, de Masson A, Lepelletier C, Jachiet M, Salle de Chou C, Galicier L, Bagot M, Chevret S, Bouaziz JD.

J Am Acad Dermatol. 2019 Jun;80(6):1544-1549. doi: 10.1016/j.jaad.2018.03.043. Epub 2019 Apr 10.

PMID:
30981429
17.

Risk of severe maternal morbidity associated with cesarean delivery and the role of maternal age: a population-based propensity score analysis.

Korb D, Goffinet F, Seco A, Chevret S, Deneux-Tharaux C; EPIMOMS Study Group.

CMAJ. 2019 Apr 1;191(13):E352-E360. doi: 10.1503/cmaj.181067.

18.

Immune checkpoint blockade toxicity among patients with cancer presenting to the emergency department.

Peyrony O, Tieghem Y, Franchitti J, Ellouze S, Morra I, Madelaine-Chambrin I, Flicoteaux R, Baroudjian B, Azoulay E, Chevret S, Fontaine JP.

Emerg Med J. 2019 May;36(5):306-309. doi: 10.1136/emermed-2018-208091. Epub 2019 Mar 25.

PMID:
30910911
19.

Center Effects in Hospital Mortality of Critically Ill Patients With Hematologic Malignancies.

Biard L, Darmon M, Lemiale V, Mokart D, Chevret S, Azoulay E, Resche-Rigon M.

Crit Care Med. 2019 Jun;47(6):809-816. doi: 10.1097/CCM.0000000000003717.

PMID:
30889024
20.

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure.

Sébert M, Renneville A, Bally C, Peterlin P, Beyne-Rauzy O, Legros L, Gourin MP, Sanhes L, Wattel E, Gyan E, Park S, Stamatoullas A, Banos A, Laribi K, Jueliger S, Bevan L, Chermat F, Sapena R, Nibourel O, Chaffaut C, Chevret S, Preudhomme C, Adès L, Fenaux P; Groupe Francophone des Myélodysplasies (GFM).

Haematologica. 2019 Aug;104(8):1565-1571. doi: 10.3324/haematol.2018.207118. Epub 2019 Feb 7.

21.

Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.

Bernaudin F, Verlhac S, Peffault de Latour R, Dalle JH, Brousse V, Petras E, Thuret I, Paillard C, Neven B, Galambrun C, Divialle-Doumdo L, Pondarré C, Guitton C, Missud F, Runel C, Jubert C, Elana G, Ducros-Miralles E, Drain E, Taïeb O, Arnaud C, Kamdem A, Malric A, Elmaleh-Bergès M, Vasile M, Leveillé E, Socié G, Chevret S; DREPAGREFFE Trial Investigators.

JAMA. 2019 Jan 22;321(3):266-276. doi: 10.1001/jama.2018.20059.

22.

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis.

Robin M, Chevret S, Koster L, Wolschke C, Yakoub-Agha I, Bourhis JH, Chevallier P, Cornelissen JJ, Reményi P, Maertens J, Poiré X, Craddock C, Socié G, Itälä-Remes M, Schouten HC, Marchand T, Passweg J, Blaise D, Damaj G, Ozkurt ZN, Zuckerman T, Cluzeau T, Labussière-Wallet H, Cammenga J, McLornan D, Chalandon Y, Kröger N.

Haematologica. 2019 Jun;104(6):1230-1236. doi: 10.3324/haematol.2018.201400. Epub 2019 Jan 17.

23.

Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity.

Blandinières A, Gendron N, Bacha N, Bièche I, Chocron R, Nunes H, Nevo N, Rossi E, Crestani B, Lecourt S, Chevret S, Lokajczyk A, Mignon V, Kisaoglu A, Juvin K, Bertil S, Valeyre D, Cras A, Gaussem P, Israël-Biet D, Smadja DM.

Angiogenesis. 2019 May;22(2):325-339. doi: 10.1007/s10456-018-09659-5. Epub 2019 Jan 3.

PMID:
30607696
24.
25.

Echographic Assessment of Diaphragmatic Function in Duchenne Muscular Dystrophy from Childhood to Adulthood.

Fayssoil A, Chaffaut C, Ogna A, Stojkovic T, Lamothe L, Mompoint D, Meng P, Prigent H, Clair B, Behin A, Laforet P, Bassez G, Carlier R, Orlikowski D, Amthor H, Quijano Roy S, Crenn P, Chevret S, Eymard B, Lofaso F, Annane D.

J Neuromuscul Dis. 2019;6(1):55-64. doi: 10.3233/JND-180326.

PMID:
30562904
26.

Bright Light Therapy in the Morning or at Mid-Day in the Treatment of Non-Seasonal Bipolar Depressive Episodes (LuBi): Study Protocol for a Dose Research Phase I / II Trial.

Geoffroy PA, Abbassi EMBE, Maruani J, Etain B, Lejoyeux M, Amad A, Courtet P, Dubertret C, Gorwood P, Vaiva G, Bellivier F, Chevret S.

Psychiatry Investig. 2018 Dec;15(12):1188-1202. doi: 10.30773/pi.2018.09.27.1. Epub 2018 Nov 26.

27.

Intensive care medicine in 2050: clinical trials designs.

Gasparini M, Chevret S.

Intensive Care Med. 2019 May;45(5):668-670. doi: 10.1007/s00134-018-5364-9. Epub 2018 Nov 14. No abstract available.

PMID:
30430206
28.

Once-daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS-165 DARULIGHT study.

Lê MP, Chaix ML, Raffi F, Chevret S, Gallien S, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS-165 DARULIGHT study group.

Br J Clin Pharmacol. 2019 Jan;85(1):277-280. doi: 10.1111/bcp.13796. Epub 2018 Nov 12. No abstract available.

PMID:
30421447
29.

A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM).

Ades L, Guerci-Bresler A, Cony-Makhoul P, Legros L, Sebert M, Braun T, Delaunay J, Desseaux K, Chevret S, Fenaux P.

Haematologica. 2019 Apr;104(4):e131-e133. doi: 10.3324/haematol.2018.203885. Epub 2018 Oct 31. No abstract available.

30.

Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.

Azoulay E, Lemiale V, Mokart D, Nseir S, Argaud L, Pène F, Kontar L, Bruneel F, Klouche K, Barbier F, Reignier J, Berrahil-Meksen L, Louis G, Constantin JM, Mayaux J, Wallet F, Kouatchet A, Peigne V, Théodose I, Perez P, Girault C, Jaber S, Oziel J, Nyunga M, Terzi N, Bouadma L, Lebert C, Lautrette A, Bigé N, Raphalen JH, Papazian L, Darmon M, Chevret S, Demoule A.

JAMA. 2018 Nov 27;320(20):2099-2107. doi: 10.1001/jama.2018.14282.

31.

Oxygenation/non-invasive ventilation strategy and risk for intubation in immunocompromised patients with hypoxemic acute respiratory failure.

Dumas G, Chevret S, Lemiale V, Pène F, Demoule A, Mayaux J, Kouatchet A, Nyunga M, Perez P, Argaud L, Barbier F, Vincent F, Bruneel F, Klouche K, Kontar L, Moreau AS, Reignier J, Papazian L, Cohen Y, Mokart D, Azoulay E.

Oncotarget. 2018 Sep 14;9(72):33682-33693. doi: 10.18632/oncotarget.26069. eCollection 2018 Sep 14.

32.

Morbidity and Mortality of Crystalloids Compared to Colloids in Critically Ill Surgical Patients: A Subgroup Analysis of a Randomized Trial.

Heming N, Lamothe L, Jaber S, Trouillet JL, Martin C, Chevret S, Annane D.

Anesthesiology. 2018 Dec;129(6):1149-1158. doi: 10.1097/ALN.0000000000002413.

PMID:
30212412
33.

Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative Leukemia Organization (FILO) working group.

Roos-Weil D, Nguyen-Khac F, Chevret S, Touzeau C, Roux C, Lejeune J, Cosson A, Mathis S, Feugier P, Leprêtre S, Béné MC, Baron M, Raynaud S, Struski S, Eclache V, Sutton L, Lesty C, Merle-Béral H, Cymbalista F, Ysebaert L, Davi F, Leblond V; FILO working group.

Genes Chromosomes Cancer. 2018 Nov;57(11):533-540. doi: 10.1002/gcc.22650. Epub 2018 Sep 11.

34.

Heckman imputation models for binary or continuous MNAR outcomes and MAR predictors.

Galimard JE, Chevret S, Curis E, Resche-Rigon M.

BMC Med Res Methodol. 2018 Aug 31;18(1):90. doi: 10.1186/s12874-018-0547-1.

35.

Long-term results of the modified Konno procedure in high-risk children with obstructive hypertrophic cardiomyopathy.

Laredo M, Khraiche D, Raisky O, Gaudin R, Bajolle F, Maltret A, Chevret S, Bonnet D, Vouhé PR.

J Thorac Cardiovasc Surg. 2018 Dec;156(6):2285-2294.e2. doi: 10.1016/j.jtcvs.2018.06.040. Epub 2018 Jul 18.

PMID:
30104063
36.

Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.

Ganne-Carrié N, Chaffaut C, Bourcier V, Archambeaud I, Perarnau JM, Oberti F, Roulot D, Moreno C, Louvet A, Dao T, Moirand R, Goria O, Nguyen-Khac E, Carbonell N, Antonini T, Pol S, de Ledinghen V, Ozenne V, Henrion J, Péron JM, Tran A, Perlemuter G, Amiot X, Zarski JP, Beaugrand M, Chevret S; for CIRRAL Group.

J Hepatol. 2018 Dec;69(6):1274-1283. doi: 10.1016/j.jhep.2018.07.022. Epub 2018 Aug 6.

37.

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.

Lambert J, Pautas C, Terré C, Raffoux E, Turlure P, Caillot D, Legrand O, Thomas X, Gardin C, Gogat-Marchant K, Rubin SD, Benner RJ, Bousset P, Preudhomme C, Chevret S, Dombret H, Castaigne S.

Haematologica. 2019 Jan;104(1):113-119. doi: 10.3324/haematol.2018.188888. Epub 2018 Aug 3.

38.

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.

Adès L, Thomas X, Bresler AG, Raffoux E, Spertini O, Vey N, Marchand T, Récher C, Pigneux A, Girault S, Deconinck E, Gardin C, Tournilhac O, Lambert JF, Chevallier P, de Botton S, Lejeune J, Dombret H, Chevret S, Fenaux P.

Haematologica. 2018 Dec;103(12):2033-2039. doi: 10.3324/haematol.2018.198614. Epub 2018 Jul 19.

39.

A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure.

Azoulay E, Roux A, Vincent F, Kouatchet A, Argaud L, Rabbat A, Mayaux J, Perez P, Pène F, Nyunga M, Bruneel F, Klouche K, Mokart D, Darmon M, Chevret S, Lemiale V.

Am J Respir Crit Care Med. 2018 Dec 15;198(12):1519-1526. doi: 10.1164/rccm.201712-2452OC.

PMID:
29995433
40.

Natural history of cardiac function in Duchenne and Becker muscular dystrophies on home mechanical ventilation.

Fayssoil A, Ogna A, Chaffaut C, Lamothe L, Ambrosi X, Nardi O, Prigent H, Clair B, Lofaso F, Chevret S, Orlikowski D, Annane D.

Medicine (Baltimore). 2018 Jul;97(27):e11381. doi: 10.1097/MD.0000000000011381.

41.

Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation.

Meignin V, Thivolet-Bejui F, Kambouchner M, Hussenet C, Bondeelle L, Mitchell A, Chagnon K, Begueret H, Segers V, Cottin V, Tazi A, Chevret S, Danel C, Bergeron A.

Histopathology. 2018 Nov;73(5):832-842. doi: 10.1111/his.13697. Epub 2018 Aug 19.

PMID:
29953629
42.

Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.

Lê MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS 165 DARULIGHT Study Group.

J Antimicrob Chemother. 2018 Aug 1;73(8):2120-2128. doi: 10.1093/jac/dky193.

PMID:
29905808
43.

Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial.

Huguet F, Chevret S, Leguay T, Thomas X, Boissel N, Escoffre-Barbe M, Chevallier P, Hunault M, Vey N, Bonmati C, Lepretre S, Marolleau JP, Pabst T, Rousselot P, Buzyn A, Cahn JY, Lhéritier V, Béné MC, Asnafi V, Delabesse E, Macintyre E, Chalandon Y, Ifrah N, Dombret H; Group of Research on Adult ALL (GRAALL).

J Clin Oncol. 2018 Aug 20;36(24):2514-2523. doi: 10.1200/JCO.2017.76.8192. Epub 2018 Jun 4.

44.

Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight).

Molina JM, Gallien S, Chaix ML, El Abbassi EM, Madelaine I, Katlama C, Valin N, Delobel P, Desseaux K, Peytavin G, Saillard J, Raffi F, Chevret S; ANRS 165 Darulight Study Group.

J Antimicrob Chemother. 2018 Aug 1;73(8):2129-2136. doi: 10.1093/jac/dky181.

PMID:
29860402
45.

Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).

Rahmé R, Ades L, Thomas X, Guerci-Bresler A, Pigneux A, Vey N, Raffoux E, Castaigne S, Spertini O, Wittnebel S, Marolleau JP, Damaj G, Bordessoule D, Lejeune J, Chevret S, Fenaux P.

Haematologica. 2018 Nov;103(11):e519-e521. doi: 10.3324/haematol.2018.193151. Epub 2018 May 24. No abstract available.

46.

Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study.

Peffault de Latour R, Chevret S, Jubert C, Sirvent A, Galambrun C, Ruggeri A, Gandemer V, Cornillon J, Rialland F, Dalle JH, Forcade E, Bruno B, Paillard C, Rorlich PS, Salmon A, Fürst S, Sicre de Fontbrune F, Rubio MT, Bay JO, Mohty M, Larghero J, Gluckman E, Socié G; Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

Blood. 2018 Aug 16;132(7):750-754. doi: 10.1182/blood-2018-01-829630. Epub 2018 May 14.

PMID:
29760162
47.

Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia.

Renneville A, Attias P, Thomas X, Bally C, Hayette S, Farhat H, Eclache V, Marceau-Renaut A, Cassinat B, Feuillard J, Terré C, Delabesse E, Park S, Lejeune J, Chevret S, Adès L, Preudhomme C, Fenaux P.

Leukemia. 2018 Sep;32(9):2066-2069. doi: 10.1038/s41375-018-0137-6. Epub 2018 Apr 18. No abstract available.

PMID:
29740159
48.

Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning.

Robin M, Raj K, Chevret S, Gauthier J, de Lavallade H, Michonneau D, McLornan D, Peffault de Latour R, Potter V, Kulasekararaj A, Sicre de Fontbrune F, Pagliuca A, Yakoub-Agha I, Socié G, Mufti GJ.

Eur J Haematol. 2018 Oct;101(4):466-474. doi: 10.1111/ejh.13085.

PMID:
29714032
49.

Are systematic reviews and meta-analyses still useful research? No.

Chevret S, Ferguson ND, Bellomo R.

Intensive Care Med. 2018 Apr;44(4):515-517. doi: 10.1007/s00134-018-5066-3. Epub 2018 Apr 16. No abstract available.

PMID:
29663047
50.

Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation.

Bergeron A, Chevret S, Peffault de Latour R, Chagnon K, de Margerie-Mellon C, Rivière F, Robin M, Mani J, Lorillon G, Socié G, Tazi A.

Eur Respir J. 2018 May 3;51(5). pii: 1702617. doi: 10.1183/13993003.02617-2017. Print 2018 May.

PMID:
29650555

Supplemental Content

Loading ...
Support Center